Helping Protect against meningococcal B - a new vaccine for New Zealand
Bexsero, GSK's new meningococcal group B vaccine will be available from the end of October 2018. GSK are providing this educational session to update Healthcare Professionals on meningococcal disease in New Zealand and provide support with the use of this new vaccine.
Please see flyer below:
RN BN PG Cert Nursing
GSK Medical Affairs - Vaccines